Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Thomas JL, Tee MW, Harp J, Magro C. Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis. J Cutan Pathol. 2023;50(2):127-130.

Pallasaho S, Gondane A, Kuivalainen A, Girmay S, Moestue S, Loda M, et al. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7. J Cancer Res Clin Oncol. 2023;149(8):5255-5263.

Xie Q, Schenck EJ, Yang HS, Chen Y, Peng Y, Wang F. Faithful AI in Medicine: A Systematic Review with Large Language Models and Beyond. medRxiv. 2023.

Saoud C, Wakely PE, Pantanowitz L, Siddiqui MT, Ali SZ. Chondroblastoma: Cytomorphologic Analysis of 10 Cases with Review of the Literature. Acta Cytol. 2023;67(4):413-424.

Usui J, Salvatore SP, Yamagata K, Seshan SV. Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF- α Inhibitor Therapy: A Single Center Experience. Kidney360. 2023;4(3):363-373.

Noch EK, Palma LN, Yim I, Bullen N, Qiu Y, Ravichandran H, et al. Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. Neuro Oncol. 2023;25(12):2165-2176.

Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, et al. Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clin Cancer Res. 2023;29(15):2933-2943.

Camacho A, Salah F, Bay CP, Waring J, Umeton R, Hirsch MS, et al. PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection. BJUI Compass. 2023;4(4):473-481.

Boyraz B, Gogakos T, Raskin KA, Nielsen GP. Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation. Int J Gynecol Pathol. 2023;42(2):151-154.

Itkin T, Houghton S, Schreiner R, Lin Y, Badwe CR, Voisin V, et al. Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing. bioRxiv. 2023.